Sign in Welcome! Log into your account your username your password Forgot your password? Get help Password recovery Recover your password your email A password will be e-mailed to you. Veracyte Names Keith Kennedy Chief Operating Officer and Chief Financial Officer By Admin July 1, 2019 NewslettersLook Who’s On the Move! Share Facebook Twitter Pinterest WhatsApp Linkedin Email Print SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte Names Keith Kennedy Chief Operating Officer and Chief Financial Officer… http://www.businesswire.com/news/home/20190701005314/en/Veracyte-Names-Keith-Kennedy-Chief-Operating-Officer First Name * Email * Last Name * Country * Lists 02_NEWSLETTER: ANNOUNCEMENTS 02_NEWSLETTER: BIOTECHNOLOGY 02_NEWSLETTER: EDITOR´S PICK 02_NEWSLETTER: FEATURED ARTICLE 02_NEWSLETTER: HOSPITAL NEWS 02_NEWSLETTER: INDUSTRY NEWS 02_NEWSLETTER: LOOK WHO IS ON THE 02_NEWSLETTER: MEDICAL DEVICES 03_NEWSLETTER: NATALIE YEADON 02_NEWSLETTER: REGULATORY AFFAIRS 02_NEWSLETTER: CLINICAL TRIALS Recent Articles Exicure Granted Orphan Drug Designation by the U.S. Food and Drug Administration for Cavrotolimod Industry News March 4, 2021 AavantiBio Adds Veteran Life Sciences Executive Douglas J. Swirsky as Chief Financial Officer and Treasurer Look Who’s On the Move! March 4, 2021 Xentria Announces Submission of an Investigational New Drug (IND) Application for XTMAB-16 in the Treatment of Sarcoidosis Regulatory Affairs March 4, 2021 Quantum Materials Corp Expands Executive Leadership Team To Execute Growth Strategy Look Who’s On the Move! March 4, 2021 Repertoire Immune Medicines Pre-publishes New Research Identifying Potential Mechanisms for Immune Escape of SARS-CoV-2 Variants to Support Novel Approaches for T Cell Based Therapeutic... Industry News March 4, 2021 Sign in / Join